NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This trial investigate add-on treatment with 3 g NAC vs. placebo in 20 weeks in patients suffering from bipolar depression. The primary outcome is MADRS-score, and the secondary outcomes are other psychometric evaluations oxidative stress biomarkers in urine.
Epistemonikos ID: 9747f890826515f051518118ad36b63257d652f8
First added on: May 12, 2024